Regulators are considering whether to authorize the pill’s emergency use in adults who have been experiencing symptoms for less than five days and, if so, how to define who’s considered high risk.Read More

Regulators are considering whether to authorize the pill’s emergency use in adults who have been experiencing symptoms for less than five days and, if so, how to define who’s considered high risk.Read More